Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression

NCT00481026 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT00481026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression
Lead sponsor
Bayside Health
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2013
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, schizophrenia